E.D.T Sample Clauses

E.D.T. If the deposit into the Escrow Account is made by certified check or Federal Funds wire transfer and received by the Escrow Agent after 10:00 a.m. E.D.T., the Escrow Agent shall invest the funds deposited on the next business day. If the deposit into the Escrow Account is made by clearinghouse check, the Escrow Agent shall invest the funds deposited on the next business day following the receipt of the clearinghouse check.
E.D.T. All interested parties are invited to listen to a live Web cast of the conference call through the investor relations section of the Manhattan Associates Web site. To listen to the Web cast, please go to the Web site at least 15 minutes early to download and install any necessary audio software. For those who cannot listen to the live broadcast, a replay will be available shortly after the call by dialing +1.800.642.1687 in the U.S. or Canada and +1.706.645.9291 if outside txx X.X., xxxxxxation number 8641514, or vix xxx Xxx xx xxw.manh.com. The phone replay and the Internet broadcast will be avaixxxxx xxxxx Manhattan Associates' next earnings call. About Manhattan Associates, Inc. Manhattan Associates, Inc., is the global leader in providing supply chain execution and optimization solutions. It enables operational excellence through its warehouse, transportation, distributed order management, reverse logistics and trading partner management solutions, as well as its RFID, performance management and event management capabilities. These Integrated Logistics Solutions(TM) leverage state-of-the-art technologies, innovative practices and domain expertise to enhance performance, profitability and competitive advantage. Manhattan Associates has licensed more than 900 customers representing more than 1,600 facilities worldwide, which include some of the world's leading manufacturers, distributors and retailers. For more information about Manhattan Associates, visit www.manh.com. This press release may contain "forward-looking statemexxx" xxxxxxxg to Manhattan Associates, Inc. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are delays in product development, undetected software errors, competitive pressures, technical difficulties, market acceptance, availability of technical personnel, changes in customer requirements, risks of international operations and general economic conditions. Additional factors are set forth in "Safe Harbor Compliance Statement for Forward-Looking Statements" included as Exhibit 99.1 to the Company's Annual Report on Form 10-K for the year ended December 31, 2004. Manhattan Associates undertake...
E.D.T. Pxxxx Xxxxx, chief executive officer of ArQule, will lead the call. As a result of entering into the exclusive license agreement, ArQule will be updating its financial guidance on the call. Confidential Materials omitted and filed separately with the Securities and Exchange Commission. ***Triple asterisks denote omissions. Licence Agreement/ArQule, Inc. The details of the call are as follows: April [], 2018 @ 9 AM EDT Audio connection numbers: US: 1 000-000-0000 Outside US: 1 000-000-0000 PIN: 4089669 A replay of the call will be available two hours after the completion of the call and can be accessed in the “Investors and Media” section of our website, wxx.xxxxxx.xxx, under “Events and Presentations.” The ArQule investor conference call will be archived and can be accessed in the “Investors and Media” section of ArQule’s website, wxx.xxxxxx.xxx, under “Events and Presentations.” About Derazantinib Derazantinib is a potent, orally administered inhibitor of the fibroblast growth factor receptor (FGFR) family, a key driver of cell proliferation, differentiation, and migration. In a Phase 1/2 study in patients with iCCA harboring FGFR2 gene fusions, treatment with derazantinib resulted in an objective response rate of 21%, nearly 3 times higher than standard-of-care chemotherapy. ArQule is currently conducting a registrational study with derazantinib in patients with FGFR2 fusion-positive second-line iCCA. The open-label single-arm trial is recruiting in both the United States and Europe with objective response rate as the primary endpoint. More information on that program is available here. About Intrahepatic Cholangiocarcinoma Cholangiocarcinoma (CCA) is the most common biliary malignancy and the second most common hepatic malignancy after hepatocellular carcinoma (HCC).1 Depending on the anatomic location, CCA is classified as intrahepatic (iCCA), perihilar (pCCA), and extrahepatic (eCCA). iCCA originates from the intrahepatic biliary ductal system and forms an intrahepatic mass. iCCA is an aggressive cancer, with a median 5-year survival rate of 15% for patients diagnosed with early-stage disease.2 In China, the incidence of cholangiocarcinoma is more than 7 cases per 100,000 people, and the majority of cases are intrahepatic.3 About ArQule ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and rare diseases. ArQule's mission is to discover, develop and commercialize novel small molecule...
E.D.T. Client may elect to capture its own Data and to transmit such Data to Fidelity for processing through electronic data transmission ("EDT"), and/or to receive reports by EDT. Client shall be responsible for acquiring at its own expense all equipment needed for such transmission unless otherwise provided as part of this Agreement. If equipment is not provided, as part of this Agreement, then Client equipment shall conform to Fidelity specifications and applicable rules. After installation, and prior to the commencement of transmission, Client shall notify Fidelity and Fidelity shall inspect the equipment, and if such equipment conforms to all applicable Fidelity specifications, Fidelity shall certify thereto.

Related to E.D.T

  • Central Time After all Parties have been notified, the provisions of paragraphs (b) and (c) of this Section 2.1 shall apply." All other terms and provisions of the Agreement not amended herein shall remain in full force and effect. Effective date: March 18, 2008 AIM VARIABLE INSURANCE FUNDS Attest: /s/ Xxxxx Xxxxxxxx By: /s/ Xxxxxxx X. Xxxxx ----------------------------- ------------------------------------ Name: Xxxxx Xxxxxxxx Name: Xxxxxxx Xxxxx Title: Assistant Secretary Title: Assistant Vice President A I M DISTRIBUTORS, INC. Attest: /s/ Xxxxx Xxxxxxxx By: /s/ Xxxx X. Xxxxxx ----------------------------- ------------------------------------ Name: Xxxxx Xxxxxxxx Name: Xxxx X. Xxxxxx Title: Assistant Secretary Title: President GENWORTH LIFE INSURANCE COMPANY OF NEW YORK Attest: /s/ Xxxxx X. Xxxxxx By: /s/ Xxxxxxx X. Xxxxxx ----------------------------- ------------------------------------ Name: Xxxxx X. Xxxxxx Name: Xxxxxxx X. Xxxxxx Title: Assistant Secretary Title: Vice President and Associate General Counsel CAPITAL BROKERAGE CORPORATION

  • Lieu Time A Department Head or designate may at his/her discretion allow time off regular working hours in lieu of overtime payment at the applicable overtime rate, when requested by the employee and at a time mutually agreeable. Such lieu time off work may only be taken at non-peak or slower work time periods. For in lieu of overtime payment purposes, not more than five (5) days of time off shall be earned and taken by an employee in any one calendar year. These days off are not transferable to the next year. The accumulated overtime hours shall be taken as time off with pay in full days. All overtime hours worked in one work period must be designated either paid for or scheduled for lieu time off - it is not permissible to split the time. Lieu time will not be considered for overtime work periods of less than one (1) hour. (1990)(2004)

  • Work Time A. Work time includes time during which an employee:

  • EST on the next following Business Day. For purposes of this Agreement, "Business Day" shall mean any day on which the New York Stock exchange is open for trading.

  • Monday morning (2) The employee should not work more than 16 hours without an 8 hour break.

  • Flex Time Upon agreement of the supervisor's immediate supervisor, an individual flex-time schedule may be established.

  • Response Time PROVIDING PARTY shall respond to and resolve any problems in connection with the Corporate Services for RECEIVING PARTY within a commercially reasonable period of time, using response and proposed resolution times consistent with its response and resolution of such problems for itself.

  • Eastern Time 1.3. The Fund agrees to make shares of the Designated Portfolios available indefinitely for purchase at the applicable net asset value per share by Participating Insurance Companies and their separate accounts on those days on which the Fund calculates its Designated Portfolio net asset value pursuant to rules of the SEC and the Fund shall use reasonable efforts to calculate such net asset value on each day the New York Stock Exchange is open for trading; provided, however, that the Board of Trustees of the Fund (the "Fund Board") may refuse to sell shares of any Portfolio to any person, or suspend or terminate the offering of shares of any Portfolio if such action is required by law or by regulatory authorities having jurisdiction or is, in the sole discretion of the Fund Board, acting in good faith and in light of its fiduciary duties under federal and any applicable state laws, necessary in the best interests of the shareholders of such Portfolio.

  • Business Time During the Employment Period, the Executive agrees to devote full attention during normal business hours to the business and affairs of the Company and Affiliates and to use the Executive's best efforts to perform faithfully and efficiently the responsibilities assigned to the Executive hereunder, to the extent necessary to discharge such responsibilities, except for (i) time spent in managing the Executive's personal, financial and legal affairs and serving on corporate, civic or charitable boards or committees, in each case only if and to the extent not substantially interfering with the performance of such responsibilities, and (ii) periods of vacation and sick leave to which the Executive is entitled. It is expressly understood and agreed that the Executive's continuing to serve on any boards and committees on which the Executive is serving or with which the Executive is otherwise associated immediately preceding the Effective Date shall not be deemed to interfere with the performance of the Executive's services to the Company or Affiliates.

  • Show Up Time An employee who reports to work in the usual manner without having been notified that there is no work available and is sent home because of lack of work before having worked four (4) hours shall receive a minimum of four (4) hours pay at their prevailing hourly rate. The employee shall also receive their full accommodation allowance if and when applicable. Each employee must inform the Employer of a means of being contacted on short notice. If an attempt is made by the Employer at least two (2) hours before the employee’s shift commences by way of the contact information provided, in an effort to inform the employee of a lack of work, and the Employer is unable to do so, the employee will not be entitled to show up time.